BEATW
Heartbeam, Inc. WarrantstockNASDAQWarrant
heartbeam developed a mhealth technology that is diagnostically equivalent to a cardiologist reading a patient's 12 lead ecg and examining the patient. it comprises a credit card size, 12 lead equivalent, ecg device and a cloud-based diagnostic expert system. studies designed by harvard medical school faculty have shown heartbeam performance to be equal or better than world class cardiologists in diagnosing a heart attack. the technology features personalized diagnostic thresholds and novel heart attack ecg markers from which the application can also help cardiologists locate a heart attack on a 3d model of the heart. heartbeam's icardiologist application utilizes artificial intelligence / machine learning to drive continuous improvements of the system's ability to provide patient analysis and improve the solution's predictive properties.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 0.00 | 2026-11-11 | +247.06% | 197.807 |
| 1M | 0.02 | 2026-10-19 | -41.58% | -6.631 |
| 3M | 0.02 | 2026-08-17 | -21.33% | 0.968 |
| 6M | 0.10 | 2026-05-19 | -87.71% | -0.338 |
| 1Y | 0.30 | 2025-11-18 | -96.07% | -0.838 |
| 2Y | 0.70 | 2024-11-18 | -98.31% | — |
| 5Y | 1.15 | 2021-11-18 | -98.97% | -1.013 |
Heartbeam, Inc. Warrant (NASDAQ:BEATW) stock price today is $0.01, and today's volume is 840,350. The 30 day average volume is 157,520. BEATW market cap is $32,450 with 2.75M shares outstanding.